Á¤Á÷ÇÏ°í ¼º½ÇÇÑ Áø·á, ÀÚ°¡¸é¿ªÁúȯ ¸íÀÇ
°û½Â±â ±³¼ö´Â ¿ì¸®³ª¶ó¿¡¼ óÀ½À¸·Î ³»°ú ¿Ü·¡¿¡¼ ·ù¸¶Æ¼½º ȯÀÚÀÇ Áø·á¸¦ ½ÃÀÛÇÑ ¼¿ï¼º¸ðº´¿ø¿¡¼ ÀÚ°¡¸é¿ªÁúȯÀÇ ¸íÀǷΠȯÀÚ¸¦ Ä¡·áÇϰí ÀÖ´Ù. Áø·á »Ó ¾Æ´Ñ ¿¬±¸Àڷμ »õ·Î¿î Ä¡·á¹ýÀ» °³¹ßÇϱâ À§ÇØ ³ë·ÂÇϰí Àִµ¥, 2009³âºÎÅÍ ¸é¿ªÇÐ ºÐ¾ßÀÇ È°¹ßÇÑ ±âÃÊ ¹× ÀÌÇ༺ ¿¬±¸¸¦ ¼öÇàÇØ ¸é¿ªÇÐ ¹ßÀü¿¡ À̹ÙÁöÇÏ¿´°í 2023³â¿¡´Â ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ Ãѹ«À§¿øÀåÀ» ¿ªÀÓÇÏ¸ç ¸é¿ªÇÐÀÇ Çй®Àû ¹ßÀü°ú Àü¹®°¡ ´Üü·Î¼ÀÇ »çȸÀû Ã¥¹«¿¡ Èû½á ÇÐȸÀÇ µµ¾àÀ» À̲ø¾î °úÇбâ¼úÁ¤º¸Åë½ÅºÎÀå°ü ǥâÀ» ¼ö»óÇß´Ù.
| Á¦ ¸ñ | A single-centre retrospective study of factors affecting steroid-free remission of immunoglobulin G4-related disease conducted in South Korea: A notable outcome after complete resection | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2024.05 | ¹ßÇ¥Áö | MODERN RHEUMATOLOGY |
| Á¦ ¸ñ | Kynurenine pathway can be a potential biomarker of fatigue in primary Sjögren's syndrome | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2023.12 | ¹ßÇ¥Áö | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| Á¦ ¸ñ | Predictors for future development of systemic lupus erythematosus in Korean Sjogren's syndrome patients | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2023.10 | ¹ßÇ¥Áö | LUPUS |
| Á¦ ¸ñ | Mesenchymal Stem/Stromal Cell-Based Therapies in Systemic Rheumatic Disease: From Challenges to New Approaches for Overcoming Restrictions | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2023.06 | ¹ßÇ¥Áö | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |

°¡Å縯´ë¼¿ï¼º¸ðº´¿øÀº 1980³â °³² Áö¿ª ÃÖÃÊÀÇ Á¾ÇÕº´¿øÀ¸·Î ¼¼¿öÁ³´Ù. ÇöÀç Áö»ó 22Ãþ, ÁöÇÏ 6ÃþÀÇ 1355º´»ó ±Ô¸ð¸¦ °®Ãß°í ÀÖÀ¸¸ç ´ÜÀÏ °Ç¹° º´¿øÀ¸·Î´Â ±¹³» ÃÖ´ë ±Ô¸ðÀÌ´Ù. °¡Å縯´ë¼¿ï¼º¸ðº´¿øÀº °¡Å縯±³È¸ÀÇ ´ëÇ¥ º´¿øÀ¸·Î °¡Å縯Áß¾ÓÀÇ·á¿øÀÇ ÀÌ³ä ½Çõ¿¡ Àû±Ø ¾ÕÀå¼°í ÀÖÀ¸¸ç, ȯÀÚ¸¦ ¸ÕÀú »ý°¢ÇÏ´Â Àü¹®¼¾ÅÍ Áß½ÉÀÇ º´¿ø, 21¼¼±â ÃÖ÷´Ü ÀÇ·á ½Ã½ºÅÛ º´¿øÀ¸·Î °Åµì³ª°í ÀÖ´Ù.
¼¿ïƯº°½Ã ¼Ãʱ¸ ¹ÝÆ÷´ë·Î 222